Your session is about to expire
← Back to Search
Blue light phototherapy for Grover's Disease
Study Summary
This trial will see if blue-light therapy can improve symptoms in patients with psoriasis or Grover's Disease.
- Grover's Disease
- Plaque Psoriasis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many people are being enrolled in this investigation?
"Affirmative. Clinicaltrials.gov hosts data verifying that this investigation is currently enlisting participants, which was initially posted on September 1st 2020. Just 20 individuals need to be recruiting from one location for the trial to commence."
Who meets the criteria for participation in this clinical experiment?
"This clinical trial is aiming to recruit 20 adults aged 18-89 who have been medically diagnosed with psoriasis vulgaris or Grover's disease."
Does this experiment enlist participants who are more than 30 years old?
"To be eligible for this particular trial, individuals must be aged between 18 and 89. There are 31 additional trials available to those under the age of consent, as well as 143 studies tailored for patients above 65 years old."
Is this research endeavor in need of additional participants?
"Affirmative. According to clinicaltrials.gov, this particular medical trial is actively recruiting participants since it was published on September 1st 2020 and updated for the last time on June 8th 2022. 20 potential patients must be sourced from a solitary site."
Share this study with friends
Copy Link
Messenger